BibTex RIS Cite

-

Year 2011, Volume: 24 Issue: 2, 123 - 125, 21.04.2015

Abstract

-

References

  • 1. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009;116:497-503. doi: 10.1016/j.ophtha.2008.10.016
  • 2. Akman F, Cerman E, Yenice O, Kazokoglu H. Two cases with chloroquine and hydroxychloroquine maculopathy. Marmara Med J 2011;24:68-72. doi:10.5472/MMJ.2010.01575.2
  • 3. Brancato R. Optical coherence tomography (OCT) in macular edema. Doc Ophthalmol 1999;97:337-9.
  • 4. O' Doherty M , Dooley I, Hickey-Dwyer M . Interventions for diabetic macular oedema: a systematic review of the literature. Br J Ophthalmol 2008;92:1581-90. doi:10.1136/bjo.2008.144550
  • 5. Soliman W, Sander B, Hasler PW, Larsen M. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography. Acta Ophthalmol 2008;86:34-9. doi:10.1111/j.1600-0420.2007.00989.x
  • 6. Nguyen QD, Shah SM, Van Anden E, et al. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 2004 ;45:617-24. doi:10.1016/j.ajo.2004.02.096
  • 7. Shimada H, Akaza E, Yuzawa M, Kawashima M. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 2009;50:2953-5. doi:10.1167/iovs.08-2870
  • 8. Kiernan DF, Mieler WF. The use of intraocular corticosteroids. Expert Opin Pharmacother 2009;10:2511-25. doi:10.1517/14656560903160671
  • 9. Onal S, Bavbek T. Aging and the eye. Marmara Med J 2005;18:43-52.
  • 10. Harbour JW, Smiddy WE, Flynn HW, Jr., Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996; 121:405-13.
  • 11. Ikeda T, Sato K, Katano T, Hayashi Y. Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 2000;20:220-2. doi:10.1097/00006982-200002000-00023
  • 12. Watanabe M, Oshima Y, Emi K. Optical crosssectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol 2000; 129:264-7. doi:10.1016/S0002-9394(99)00284-6

Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi

Year 2011, Volume: 24 Issue: 2, 123 - 125, 21.04.2015

Abstract

Diyabetik maküla ödeminde tedavi seçenekleri fazladır. Bu yüzden diyabetik maküla ödemi tedavi seçenekleri arasında doğru kombinasyona karar verirken altta yatan fizyolojik mekanizmaları anlamak önemlidir. Burada altta yatan fizyolojik mekanizmaları göz önünde bulundurarak diyabetik maküla ödeminin tedavi seçeneklerini kısaca gözden geçirdik.

Anahtar Kelimeler: Diyabet, Maküla ödemi, Starling yasası

References

  • 1. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009;116:497-503. doi: 10.1016/j.ophtha.2008.10.016
  • 2. Akman F, Cerman E, Yenice O, Kazokoglu H. Two cases with chloroquine and hydroxychloroquine maculopathy. Marmara Med J 2011;24:68-72. doi:10.5472/MMJ.2010.01575.2
  • 3. Brancato R. Optical coherence tomography (OCT) in macular edema. Doc Ophthalmol 1999;97:337-9.
  • 4. O' Doherty M , Dooley I, Hickey-Dwyer M . Interventions for diabetic macular oedema: a systematic review of the literature. Br J Ophthalmol 2008;92:1581-90. doi:10.1136/bjo.2008.144550
  • 5. Soliman W, Sander B, Hasler PW, Larsen M. Correlation between intraretinal changes in diabetic macular oedema seen in fluorescein angiography and optical coherence tomography. Acta Ophthalmol 2008;86:34-9. doi:10.1111/j.1600-0420.2007.00989.x
  • 6. Nguyen QD, Shah SM, Van Anden E, et al. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci 2004 ;45:617-24. doi:10.1016/j.ajo.2004.02.096
  • 7. Shimada H, Akaza E, Yuzawa M, Kawashima M. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 2009;50:2953-5. doi:10.1167/iovs.08-2870
  • 8. Kiernan DF, Mieler WF. The use of intraocular corticosteroids. Expert Opin Pharmacother 2009;10:2511-25. doi:10.1517/14656560903160671
  • 9. Onal S, Bavbek T. Aging and the eye. Marmara Med J 2005;18:43-52.
  • 10. Harbour JW, Smiddy WE, Flynn HW, Jr., Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996; 121:405-13.
  • 11. Ikeda T, Sato K, Katano T, Hayashi Y. Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 2000;20:220-2. doi:10.1097/00006982-200002000-00023
  • 12. Watanabe M, Oshima Y, Emi K. Optical crosssectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol 2000; 129:264-7. doi:10.1016/S0002-9394(99)00284-6
There are 12 citations in total.

Details

Primary Language Turkish
Journal Section Review Makaleler
Authors

Eren Çerman This is me

Publication Date April 21, 2015
Published in Issue Year 2011 Volume: 24 Issue: 2

Cite

APA Çerman, E. (2015). Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi. Marmara Medical Journal, 24(2), 123-125.
AMA Çerman E. Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi. Marmara Med J. August 2015;24(2):123-125.
Chicago Çerman, Eren. “Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi”. Marmara Medical Journal 24, no. 2 (August 2015): 123-25.
EndNote Çerman E (August 1, 2015) Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi. Marmara Medical Journal 24 2 123–125.
IEEE E. Çerman, “Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi”, Marmara Med J, vol. 24, no. 2, pp. 123–125, 2015.
ISNAD Çerman, Eren. “Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi”. Marmara Medical Journal 24/2 (August 2015), 123-125.
JAMA Çerman E. Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi. Marmara Med J. 2015;24:123–125.
MLA Çerman, Eren. “Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi”. Marmara Medical Journal, vol. 24, no. 2, 2015, pp. 123-5.
Vancouver Çerman E. Diyabetik Maküla Ödemi Tedavisinde Fizyolojik Mekanizmaların Önemi. Marmara Med J. 2015;24(2):123-5.